Showing results (71-80 of 88) with videos related to

Sort By:
Pageof 9
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|April 25, 2018
Dual PI3 K/mTOR inhibition reduces prostate cancer bone engraftment altering tumor-induced bone remodelingAndrea Mancini, Alessandro Colapietro, Simona Pompili, et al.
Molecules (Basel, Switzerland)|January 11, 2022
Anti-Inflammatory Activity of a CB2 Selective Cannabinoid Receptor Agonist: Signaling and Cytokines Release in Blood Mononuclear CellsAntonella Capozzi, Daniela Caissutti, Vincenzo Mattei, et al.
Rheumatology (Oxford, England)|July 9, 2018
Autophagy induces protein carbamylation in fibroblast-like synoviocytes from patients with rheumatoid arthritisValeria Manganelli, Serena Recalchi, Antonella Capozzi, et al.
Cancers|January 21, 2022
ATX-101, a Peptide Targeting PCNA, Has Antitumor Efficacy Alone or in Combination with Radiotherapy in Murine Models of Human GlioblastomaGiovanni Luca Gravina, Alessandro Colapietro, Andrea Mancini, et al.
Cells|October 28, 2025
Dental Pulp Stem Cell-Derived Organoids: Advancing the Development of 3D StructuresLoreto Lancia, Fanny Pulcini, Emanuela Mari, et al.
Cancers|August 29, 2024
Correction: Gravina et al. ATX-101, a Peptide Targeting PCNA, Has Antitumor Efficacy Alone or in Combination with Radiotherapy in Murine Models of Human Glioblastoma. <i>Cancers</i> 2022, <i>14</i>, 289Giovanni Luca Gravina, Alessandro Colapietro, Andrea Mancini, et al.
Cancers|October 24, 2019
The Brain Penetrating and Dual TORC1/TORC2 Inhibitor, RES529, Elicits Anti-Glioma Activity and Enhances the Therapeutic Effects of Anti-Angiogenetic Compounds in Preclinical Murine ModelsGiovanni Luca Gravina, Andrea Mancini, Alessandro Colapietro, et al.
Frontiers in Cell and Developmental Biology|November 29, 2023
Lipid rafts mediate multilineage differentiation of human dental pulp-derived stem cells (DPSCs)Francesca Santilli, Jessica Fabrizi, Stefano Martellucci, et al.
Cancers|December 31, 2025
RETRACTED: Gravina et al. The Brain Penetrating and Dual TORC1/TORC2 Inhibitor, RES529, Elicits Anti-Glioma Activity and Enhances the Therapeutic Effects of Anti-Angiogenetic Compounds in Preclinical Murine Models. <i>Cancers</i> 2019, <i>11</i>, 1604Giovanni Luca Gravina, Andrea Mancini, Alessandro Colapietro, et al.
Frontiers in Pharmacology|April 11, 2022
The Botanical Drug PBI-05204, a Supercritical CO<sub>2</sub> Extract of Nerium Oleander, Is Synergistic With Radiotherapy in Models of Human GlioblastomaAlessandro Colapietro, Peiying Yang, Alessandra Rossetti, et al.
Pageof 9